Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Cardiac fibroblasts and mechanosensation in heart development, health and disease

M. Pesce, GN. Duda, G. Forte, H. Girao, A. Raya, P. Roca-Cusachs, JPG. Sluijter, C. Tschöpe, S. Van Linthout

. 2023 ; 20 (5) : 309-324. [pub] 20221114

Language English Country England, Great Britain

Document type Journal Article, Review, Research Support, U.S. Gov't, Non-P.H.S.

Persistent link   https://www.medvik.cz/link/bmc23011651
E-resources Online Full text

NLK ProQuest Central from 2009-04-01 to 1 year ago
Health & Medicine (ProQuest) from 2009-04-01 to 1 year ago

Links

PubMed 36376437
DOI 10.1038/s41569-022-00799-2
Knihovny.cz E-resources

The term 'mechanosensation' describes the capacity of cells to translate mechanical stimuli into the coordinated regulation of intracellular signals, cellular function, gene expression and epigenetic programming. This capacity is related not only to the sensitivity of the cells to tissue motion, but also to the decryption of tissue geometric arrangement and mechanical properties. The cardiac stroma, composed of fibroblasts, has been historically considered a mechanically passive component of the heart. However, the latest research suggests that the mechanical functions of these cells are an active and necessary component of the developmental biology programme of the heart that is involved in myocardial growth and homeostasis, and a crucial determinant of cardiac repair and disease. In this Review, we discuss the general concept of cell mechanosensation and force generation as potent regulators in heart development and pathology, and describe the integration of mechanical and biohumoral pathways predisposing the heart to fibrosis and failure. Next, we address the use of 3D culture systems to integrate tissue mechanics to mimic cardiac remodelling. Finally, we highlight the potential of mechanotherapeutic strategies, including pharmacological treatment and device-mediated left ventricular unloading, to reverse remodelling in the failing heart.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011651
003      
CZ-PrNML
005      
20230801133227.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41569-022-00799-2 $2 doi
035    __
$a (PubMed)36376437
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pesce, Maurizio $u Unità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, IRCCS, Milan, Italy. maurizio.pesce@ccfm.it $1 https://orcid.org/0000000230978961
245    10
$a Cardiac fibroblasts and mechanosensation in heart development, health and disease / $c M. Pesce, GN. Duda, G. Forte, H. Girao, A. Raya, P. Roca-Cusachs, JPG. Sluijter, C. Tschöpe, S. Van Linthout
520    9_
$a The term 'mechanosensation' describes the capacity of cells to translate mechanical stimuli into the coordinated regulation of intracellular signals, cellular function, gene expression and epigenetic programming. This capacity is related not only to the sensitivity of the cells to tissue motion, but also to the decryption of tissue geometric arrangement and mechanical properties. The cardiac stroma, composed of fibroblasts, has been historically considered a mechanically passive component of the heart. However, the latest research suggests that the mechanical functions of these cells are an active and necessary component of the developmental biology programme of the heart that is involved in myocardial growth and homeostasis, and a crucial determinant of cardiac repair and disease. In this Review, we discuss the general concept of cell mechanosensation and force generation as potent regulators in heart development and pathology, and describe the integration of mechanical and biohumoral pathways predisposing the heart to fibrosis and failure. Next, we address the use of 3D culture systems to integrate tissue mechanics to mimic cardiac remodelling. Finally, we highlight the potential of mechanotherapeutic strategies, including pharmacological treatment and device-mediated left ventricular unloading, to reverse remodelling in the failing heart.
650    _2
$a lidé $7 D006801
650    12
$a srdeční selhání $7 D006333
650    _2
$a srdeční komory $x patologie $7 D006352
650    _2
$a fibroblasty $x patologie $7 D005347
650    _2
$a myokard $x patologie $7 D009206
650    _2
$a remodelace komor $7 D020257
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Duda, Georg N $u Berlin Institute of Health at Charité - Universitätsmedizin, Julius Wolff Institute, Berlin, Germany $u Berlin Institute of Health at Charité - Universitätsmedizin, BIH Center for Regenerative Therapies, Berlin, Germany $1 https://orcid.org/0000000176053908
700    1_
$a Forte, Giancarlo $u International Clinical Research Center (FNUSA-ICRC), St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Girao, Henrique $u Center for Innovative Biomedicine and Biotechnology, Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, Coimbra, Portugal $u Clinical Academic Centre of Coimbra, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
700    1_
$a Raya, Angel $u Regenerative Medicine Program, Bellvitge Institute for Biomedical Research, Program for Clinical Translation of Regenerative Medicine in Catalonia, L'Hospitalet de Llobregat, Barcelona, Spain $u Biomedical Research Networking Center - Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain $u Catalan Institution for Research and Advanced Studies, Barcelona, Spain
700    1_
$a Roca-Cusachs, Pere $u Institute for Bioengineering of Catalonia, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
700    1_
$a Sluijter, Joost P G $u Division Heart and Lung, Cardiology, Experimental Cardiology Laboratory, Regenerative Medicine Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
700    1_
$a Tschöpe, Carsten $u Berlin Institute of Health at Charité - Universitätsmedizin, BIH Center for Regenerative Therapies, Berlin, Germany $u Charité - Universitätsmedizin, Department of Cardiology, Campus Virchow Klinikum, Berlin, Germany $u German Centre for Cardiovascular Research (DZHK), Berlin, Germany
700    1_
$a Van Linthout, Sophie $u Berlin Institute of Health at Charité - Universitätsmedizin, BIH Center for Regenerative Therapies, Berlin, Germany. sophie.van-linthout@bih-charite.de $u German Centre for Cardiovascular Research (DZHK), Berlin, Germany. sophie.van-linthout@bih-charite.de
773    0_
$w MED00013859 $t Nature reviews. Cardiology $x 1759-5010 $g Roč. 20, č. 5 (2023), s. 309-324
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36376437 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133223 $b ABA008
999    __
$a ok $b bmc $g 1963848 $s 1197916
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 20 $c 5 $d 309-324 $e 20221114 $i 1759-5010 $m Nature reviews cardiology $n Nat Rev Cardiol $x MED00013859
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Archiving options